Client Testimonials
Over the years we have worked with many impactful businesses and have built long-standing relationships with our clients. Read the testimonials below to find out what our clients are saying about us and how we have been able to help them.
Nodthera Ltd
“Cellomatics’ exploratory work has helped crystallise our efforts on specific fluid biomarkers of interest to progress into further translational model.”
Pete Thornton, Director of Translational Science
Capella Biosciences Ltd
“I have worked with Cellomatics on three different therapeutic antibody projects with great success. One project entailed a novel cellular transport assay which Cellomatics set up from scratch. The other two projects involved primary cell based assays which Cellomatics proved to be exceptionally competent in. The project management was also very good with regular updates and emails with our team. Time wise the projects with Cellomatics ran smoothly and to plan. The quality of work and reports met all my expectations and I found the pricing to be very competitive compared to other quotations. Overall I would not hesitate to recommend them.”
Steve Holmes PhD, Former CEO
European Biotech
“A highly professional and thorough performance, excellent reproducibility of assay data provided by a diligently working team, led to a quick project advancement to the next stage as it allowed for a clear ranking of functional efficacy of several small molecule drugs supporting the selection of an early development candidate, and thus had a major strategic impact on our project status. It has been a pleasure to work together with Cellomatics and we are looking forward to continuing this highly efficient collaboration.”
Vice President, Drug Discovery and Development
LoQus 23 Therapeutics
“We have been delighted with our interactions with Cellomatics. When I first reached out to them after a recommendation from a former colleague (who also has very high standards) with the outline requirements for cell biology assay support, I was impressed by their review of the literature which was reflected in pro-actively suggesting additional, complementary assay options. This was further bolstered by exemplary attention to detail when putting together a work package proposal which was then efficiently executed. Even better, the interactions around the lab-based activities and data generation have been nothing short of ideal. The skillset, responsiveness, knowledge based, effort, effectiveness, transparent and regular communication are all outstanding. I have no hesitation whatsoever in recommending Cellomatics as an in vitro bioassay provider. We are increasingly viewing Cellomatics as our key go-to CRO for cell-biology activities to support our programmes. Our confidence in Cellomatics’ capabilities triggered the decision to engage further with additional decision-making activities critical for drug discovery and development.”
Dr Caroline Benn, CSO
Astra Zeneca, UK
“Cellomatics have been providing CRO support for AstraZeneca pre-clinical safety over the past 3 years. Working with their team of skilled scientists has enabled our timelines to progress with pace and agility. They have provided key quality datasets for IND submissions under pressure of aggressive time lines without faulter. We look forward to continuing our work together.”
Safety Scientist
European Biotech
“As a small biotech relying on extensive outsourcing, we highly value Cellomatics’ expertise and ability to engage scientifically in our projects. Collaboration with the Cellomatics team has helped us move forward important strategic goals in our biomarker development.”
CSO
Enveda Biosciences
“I have been working with Cellomatics for over 4 years in multiple projects in the areas of inflammation and oncology. Some of the projects were customized to suit our needs. The scientific team at Cellomatics were very efficient and proactive in helping us setting up the experiments. The project management team at Cellomatics has been doing a fantastic job by providing timely updates and regular communication. It has been an absolute pleasure working with Cellomatics and we look forward to more productive and fruitful collaboration in future.”
Indranil Mukhopadhyay, Assistant Vice President
Exvastat Ltd
“We were very impressed with the work that Cellomatics performed for us. This was not a straightforward model to establish and derive results in a short time frame, despite some literature references to base the work upon. Cellomatics produced a high quality report based on data that supported the original hypothesis.”
David Cavalla, CEO
